Regulatory
FDA and Drug Marketing: Are Times A-Changing?
Less restrictive rules on drug advertising and promotion may be emerging from FDA, as the agency responds to high court decisions questioning government actions that curb communications, particularly truthful statements. Jill Wechsler reports. ...Read more
Event
iPharma 2015 — CBI’s Marketing Innovation Summit | May 14–15, New York, NY
Tap into the latest trends in life sciences technology, content and communications – only at iPharma 2015! Inspirational keynotes Jeremy Bloom and Rand Fishkin anchor the meeting along with industry leaders representing Novartis, GSK, Alcon, Boehringer, Lundbeck, GE Healthcare, BMS, Shire, Takeda, Biogen, Purdue, J&J, Pfizer, Bayer and many more! Plus, don’t miss PharmExec’s prestigious Brand of the Year unveiling during a special awards ceremony. Register now or learn more at www.cbinet.com/ipharma ...Read more
Digital Marketing According to HIPAA
How pharmaceutical companies can break through regulatory constraints to create personal, audience-driven marketing content
 Learn more.
Technology
Data is Now the Key to Marketing
Neil Gleghorn, looks at the upsurge of technology and metric-driven marketing operations in the strictly regulated pharmaceutical industries ...Read more
Strategy
In a Dynamic Healthcare Market, Only the Adaptive Survive
“It is not the strongest of the species that survives... It is the one that is most responsive to change.” In today’s healthcare market, these words attributed to Darwin have never been more relevant, writes Brad Ansley
...Read more
|
|
|
 //SYGNIS (Madrid, Spain and Heidelberg, Germany) appointed Dr. Miguel-Antonio Viribay as Vice President Sales and Marketing.//Castle Biosciences (Friendswood, TX) hired Timothy Decker as VP of Marketing.//Tute Genomics (Provo, UT) appointed Josh Forsythe as VP of Marketing. //OMNIlife science (East Taunton, MA) announced the appointment of Steven Nunes as Senior VP of Sales and Marketing.// |
|
